Arlington Trust’s Exact Sciences EXAS Stock Holding History

Arlington Trust’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-85	Closed	-$8.63K	–	847
2025 Q4	$8.63K	Hold	85	–	–	﹤0.01%	326
2025 Q3	$4.65K	Hold	85	–	–	﹤0.01%	527
2025 Q2	$4.52K	Hold	85	–	–	﹤0.01%	534
2025 Q1	$3.68K	Buy	+85	New	+$4.3K	﹤0.01%	575
2024 Q1	–	Sell	-54	Closed	-$4K	–	625
2023 Q4	$4K	Buy	+54	New	+$3.54K	﹤0.01%	503

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Arlington Trust's EXAS Position: Q1 2026 in Review

Arlington Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 85 shares — an estimated $8.63K sold.

Arlington Trust first reported a position in EXAS in Q4 2023 and held it in 5 quarters. The position peaked at $8.63K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Arlington Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Arlington Trust sold 85 Exact Sciences shares in Q1 2026, an estimated $8.63K.
Arlington Trust first reported a position in Exact Sciences in Q4 2023 and held it in 5 quarters.
Arlington Trust's Exact Sciences position peaked at $8.63K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Arlington Trust's 13F filing for Q1 2026, filed 8 Apr 2026.